PR Newswire February 18, 2020
Frost & Sullivan

High adoption of annuity-based reimbursement programs by payers and therapy manufacturers will unlock the potential of gene therapies, finds Frost & Sullivan

SANTA CLARA, Calif., — Despite rising trade tension and a sluggish economic outlook for 2020, the global healthcare industry is set for an invigorating year due to a partial realization of major healthcare policies and initiatives and technology advancements. Moreover, value-based care is driving the adoption and need for consumer-centric targeted therapies. Retail giants such as Amazon, Walmart, CVS, Ali Health, and Best Buy will continue to make further headway into the individual care space, driving the “comparison shopping” consumer trend for healthcare services and products. With these trends, the overall global healthcare market is poised...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, HIE (Interoperability), Market Research, Patient / Consumer, Payment Models, Provider, Retail care, Retailer, Technology, Telehealth, Trends, Value Based, Wearables
Health care waste exposed [PODCAST]
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Pelago Defies Digital Health Funding Drought, Raises $58M
As Change reviews data impacted by cyberattack, here's what the notification process could look like

Share This Article